Loading...

Danielle Brandman, MD, MAS

Title(s)Associate Professor, Medicine
SchoolSchool of Medicine
Phone415-514-1094
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    University of California, San Francisco Residency 2008Internal Medicine
    University of California, San FranciscoFellowship2011Gastroenterology
    University of California, San FranciscoM.A.S. in Clinical Research2011Advanced Training in Clinical Research
    University of California, San FranciscoFellowship2012Transplant Hepatology
    Collapse Awards and Honors
    UCSF2015Haile T. Debas Academy of Medical Educators, Excellence in Teaching Award
    CTSI Resident Research Program2016Resident Mentor of the Year

    Collapse ORNG Applications 
    Collapse Websites

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Brandman D. Who Should Treat Fatty Liver Disease: Primary Care or Hepatology? Clin Liver Dis (Hoboken). 2019 Jun; 13(6):158-161. PMID: 31316762.
      View in: PubMed
    2. Adler E, Brandman D. Treatment of Fatty Liver Disease-Time to Implement Common Sense Measures. JAMA Intern Med. 2019 Jul 01. PMID: 31260055.
      View in: PubMed
    3. Brandman D, Lin H, McManus A, Agarwal S, Gache LM, Irish W, Gollob J, Živkovic SA. Evaluating Prognostic Factors for Liver Transplantation Among United States Patients With Hereditary Transthyretin-Mediated (hATTR) Amyloidosis Using National Registry Data. Prog Transplant. 2019 Sep; 29(3):213-219. PMID: 31167608.
      View in: PubMed
    4. Brandman D, Terrault NA. Alcohol use in patients with non-alcoholic fatty liver: a tangled web of causality. Hepatobiliary Surg Nutr. 2019 Jun; 8(3):277-279. PMID: 31245413.
      View in: PubMed
    5. Siddiqui MS, Yamada G, Vuppalanchi R, Van Natta M, Loomba R, Guy C, Brandman D, Tonascia J, Chalasani N, Neuschwander-Tetri B, Sanyal AJ. Diagnostic Accuracy of Noninvasive Fibrosis Models to Detect Change in Fibrosis Stage. Clin Gastroenterol Hepatol. 2019 Aug; 17(9):1877-1885.e5. PMID: 30616027.
      View in: PubMed
    6. Siddiqui MS, Vuppalanchi R, Van Natta ML, Hallinan E, Kowdley KV, Abdelmalek M, Neuschwander-Tetri BA, Loomba R, Dasarathy S, Brandman D, Doo E, Tonascia JA, Kleiner DE, Chalasani N, Sanyal AJ. Vibration-Controlled Transient Elastography to Assess Fibrosis and Steatosis in Patients With Nonalcoholic Fatty Liver Disease. Clin Gastroenterol Hepatol. 2019 01; 17(1):156-163.e2. PMID: 29705261.
      View in: PubMed
    7. Kushner T, Shinkai K, Fox L, Ying D, Gross A, Balitzer D, Gill R, Brandman D. New presentation of autoimmune hepatitis with erythema multiforme. Hepatology. 2018 04; 67(4):1628-1630. PMID: 29059460.
      View in: PubMed
    8. Vuppalanchi R, Siddiqui MS, Van Natta ML, Hallinan E, Brandman D, Kowdley K, Neuschwander-Tetri BA, Loomba R, Dasarathy S, Abdelmalek M, Doo E, Tonascia JA, Kleiner DE, Sanyal AJ, Chalasani N. Performance characteristics of vibration-controlled transient elastography for evaluation of nonalcoholic fatty liver disease. Hepatology. 2018 01; 67(1):134-144. PMID: 28859228.
      View in: PubMed
    9. Kardashian AA, Dodge JL, Roberts J, Brandman D. Weighing the risks: Morbid obesity and diabetes are associated with increased risk of death on the liver transplant waiting list. Liver Int. 2018 03; 38(3):553-563. PMID: 28727287.
      View in: PubMed
    10. Lewin SM, Mehta N, Kelley RK, Roberts JP, Yao FY, Brandman D. Liver transplantation recipients with nonalcoholic steatohepatitis have lower risk hepatocellular carcinoma. Liver Transpl. 2017 08; 23(8):1015-1022. PMID: 28340509.
      View in: PubMed
    11. Dakson A, Brandman D, Thibault-Halman G, Christie SD. Optimization of the mean arterial pressure and timing of surgical decompression in traumatic spinal cord injury: a retrospective study. Spinal Cord. 2017 Nov; 55(11):1033-1038. PMID: 28631747.
      View in: PubMed
    12. Brandman D. Editorial: are earlier referrals to transplant centres responsible for improved outcomes in patients with acute liver failure? Aliment Pharmacol Ther. 2017 05; 45(9):1272-1273. PMID: 28370044.
      View in: PubMed
    13. D. Brandman, M. Boyle, S. McPherson, M. Van Natta, A. Sanyal, K. Kowdley, B. Tetri, N. Chalassani, M. Abdelmalek, N.A. Terrault, A. McCullough, R. Bettencourt, C. Caussy, D. Kleiner, C. Behling, E. Doo, J. Tonascia, Q. Anstee, R. Loomba. PS-124 Comparison of clinical prediction rules for detection of cirrhosis in non-alcoholic fatty liver disease: a multicenter, international, collaborative study- NASH CRN (USA) and Newcastle (UK) Cohort. Journal of Hepatology. 2017 Jan 1; 66(1):s69-s70.
      View in: Publisher Site
    14. L. Zeng, D. Brandman, J. Roberts, N. Terrault. Early Post-Operative Outcomes in Liver Transplantation for Nonalcoholic Steatohepatitis: A Retrospective Analysis. Transplantation Journal. 2014 Jul 1; 98:740.
      View in: Publisher Site
    15. S. Epstein, D. Brandman, J. Dodge, J. Roberts, N. Terrault. Body Mass Index (BMI) and Survival After Liver Transplantation LT): Influence of the Extremes of BMI. Transplantation Journal. 2014 Jul 1; 98:740.
      View in: Publisher Site
    16. Brandman D, Bacchetti P, Ayala CE, Maher JJ, Khalili M. Impact of insulin resistance on HCV treatment response and impact of HCV treatment on insulin sensitivity using direct measurements of insulin action. Diabetes Care. 2012 May; 35(5):1090-4. PMID: 22399695.
      View in: PubMed
    17. Brandman D, Pingitore A, Lai JC, Roberts JP, Ferrell L, Bass NM, Terrault NA. Hepatic steatosis at 1 year is an additional predictor of subsequent fibrosis severity in liver transplant recipients with recurrent hepatitis C virus. Liver Transpl. 2011 Dec; 17(12):1380-6. PMID: 21770018.
      View in: PubMed
    18. Brandman D, Biggins SW, Hameed B, Roberts JP, Terrault NA. Pretransplant severe hepatic encephalopathy, peritransplant sodium and post-liver transplantation morbidity and mortality. Liver Int. 2012 Jan; 32(1):158-64. PMID: 22098119.
      View in: PubMed
    19. Canuso CM, Goldstein JM, Wojcik J, Dawson R, Brandman D, Klibanski A, Schildkraut JJ, Green AI. Antipsychotic medication, prolactin elevation, and ovarian function in women with schizophrenia and schizoaffective disorder. Psychiatry Res. 2002 Aug 05; 111(1):11-20. PMID: 12140115.
      View in: PubMed